Global Vaccine Market Report 2022
Recently the World Health Organization (WHO) has released the Global Vaccine Market Report 2022.
This is the first report to capture the effects of COVID-19 on global vaccine markets.
- The vaccine supply base is highly concentrated. Only ten manufacturers alone provide 70% of the vaccine dose (excluding COVID).
- There is a lack of uniform distribution. The African region has received only 3% of the total doses of the COVID-19 vaccine.
- Countries’ predictable demand is the key to guide investment. Thus, efforts should be focused on increasing the predictability of demand.
- Preliminary evidence-based strategic goals should be set.
- Invest in new vaccine technologies. In addition, regulatory balance must be established.
- Transparency should be ensured in terms of dissemination of intellectual property rights and inputs related to it.
- Research and development efforts should be focused on the WHO’s list of priority pathogens.
- Transparency must be ensured in the vaccine value chain.
- Equity based allocation of products should be permitted.
For International Organizations:
- According to the Immunization Agenda 2030, global public health should be a priority.
- Country-driven initiatives should be supported and duplication avoided.
- The call for implementation of resolutions on technology transfer and market transparency for healthcare products should continue.
- It is a subsidiary unit of the United Nations. This organization was established on 7th April 1948.
- The World Health Organization has 194 member countries and two affiliated members. Its aim is to raise the level of health of the people of the world.
- The headquarters of WHO is located in the city of Geneva, Switzerland.
- India became a member of WHO on January 12, 1948.
- The WHO Regional Office for South-East Asia is located in New Delhi.
Source – The Hindu